CoronaVac, also known as the Sinovac COVID-19 vaccine,[1] is an inactivated virus COVID-19 vaccine developed by Sinovac Biotech.[2] It has been in Phase III clinical trials in Brazil,[3] Chile,[4] Indonesia,[5] the Philippines,[6] and Turkey.[7]
CoronaVac, ເຊິ່ງເອີ້ນກັນວ່າ ວັກຊີນ Sinovac COVID-19, [1] ແມ່ນວັກຊີນປະເພດເຊື້ອຕາຍ ຫລື inactivated virus COVID-19 ທີ່ພັດທະນາໂດຍ Sinovac Biotech . [2] ມັນໄດ້ຢູ່ໃນໄລຍະການທົດລອງທາງດ້ານຄລີນິກ ໃນໄລຍະ III ໃນປະເທດບຣາຊິນ, [3] ຊິລີ, [4] ອິນໂດເນເຊຍ, [5] ຟີລິບປິນ, [6] ແລະ ຕັວກກີ . [7]